Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Nature
|
March 11, 2016
Support communities involved in disease studies
Ignacio Muñoz-Sanjuan
Handbook of Clinical Neurology
|
February 21, 2023
Subtyping monogenic disorders: Huntington disease
Andrea Sturchio, Andrew P Duker, Ignacio Muñoz-Sanjuan, et al.
Journal of Biomolecular Screening
|
May 22, 2013
Development of LC/MS/MS, high-throughput enzymatic and cellular assays for the characterization of compounds that inhibit kynurenine monooxygenase (KMO)
Dirk Winkler, Maria Beconi, Leticia M Toledo-Sherman, et al.
Journal of Biomolecular Screening
|
May 1, 2009
Identification of small-molecule modulators of mouse SVZ progenitor cell proliferation and differentiation through high-throughput screening
Yaping Liu, Raul Lacson, Jason Cassaday, et al.
Neurobiology of Disease
|
February 16, 2024
Diffusion MRI marks progressive alterations in fiber integrity in the zQ175DN mouse model of Huntington's disease
Nicholas Vidas-Guscic, Joëlle van Rijswijk, Johan Van Audekerke, et al.
The Lancet. Neurology
|
June 18, 2022
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
Sarah J Tabrizi, Carlos Estevez-Fraga, Willeke M C van Roon-Mom, et al.
Journal of Biomedical Science
|
April 16, 2024
Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington's disease
Tamara Vasilkovska, Somaie Salajeghe, Verdi Vanreusel, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease
John Wityak, Michael E Prime, Frederick A Brookfield, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease
Michael E Prime, Frederick A Brookfield, Stephen M Courtney, et al.
ACS Medicinal Chemistry Letters
|
May 22, 2020
Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction
Jesus M Ontoria, Ilaria Biancofiore, Paola Fezzardi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Nature
|
March 11, 2016
Support communities involved in disease studies
Ignacio Muñoz-Sanjuan
Handbook of Clinical Neurology
|
February 21, 2023
Subtyping monogenic disorders: Huntington disease
Andrea Sturchio, Andrew P Duker, Ignacio Muñoz-Sanjuan, et al.
Journal of Biomolecular Screening
|
May 22, 2013
Development of LC/MS/MS, high-throughput enzymatic and cellular assays for the characterization of compounds that inhibit kynurenine monooxygenase (KMO)
Dirk Winkler, Maria Beconi, Leticia M Toledo-Sherman, et al.
Journal of Biomolecular Screening
|
May 1, 2009
Identification of small-molecule modulators of mouse SVZ progenitor cell proliferation and differentiation through high-throughput screening
Yaping Liu, Raul Lacson, Jason Cassaday, et al.
Neurobiology of Disease
|
February 16, 2024
Diffusion MRI marks progressive alterations in fiber integrity in the zQ175DN mouse model of Huntington's disease
Nicholas Vidas-Guscic, Joëlle van Rijswijk, Johan Van Audekerke, et al.
The Lancet. Neurology
|
June 18, 2022
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
Sarah J Tabrizi, Carlos Estevez-Fraga, Willeke M C van Roon-Mom, et al.
Journal of Biomedical Science
|
April 16, 2024
Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington's disease
Tamara Vasilkovska, Somaie Salajeghe, Verdi Vanreusel, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease
John Wityak, Michael E Prime, Frederick A Brookfield, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease
Michael E Prime, Frederick A Brookfield, Stephen M Courtney, et al.
ACS Medicinal Chemistry Letters
|
May 22, 2020
Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction
Jesus M Ontoria, Ilaria Biancofiore, Paola Fezzardi, et al.
Page
of 2